Nimodipine in subarachnoid hemorrhage.

Authors

  • J M Ferro Serviço de Neurologia, Hospital de Santa Maria, Lisboa.
  • P Canhão
  • T P Melo
  • J G Campos
  • A Trindade
  • J L Antunes

DOI:

https://doi.org/10.20344/amp.3342

Abstract

The efficacy of nimodipine in decreasing mortality and morbidity of subarachnoid haemorrhage (HSA) is evaluated in 51 patients admitted to the Neurological and Neurosurgery Departments of the Santa Maria Hospital. Reductions of 2 x (0.65, 6.39) of the incidence of ischemia in the total group and of 2.1 x (0.58, 7.79) of mortality in the sub-group with initial severity of less than 4 points of the Hunt score were observed relatively to a comparable group of patients previously admitted who did not receive nimodipine. Randomized clinical trials that tested the effect of nimodipine in the context of HSA are reviewed.

Downloads

Download data is not yet available.

How to Cite

1.
Ferro JM, Canhão P, Melo TP, Campos JG, Trindade A, Antunes JL. Nimodipine in subarachnoid hemorrhage. Acta Med Port [Internet]. 1991 Jun. 30 [cited 2024 Nov. 5];4(3):138-40. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/3342

Issue

Section

Arquivo Histórico